Literature DB >> 11513140

Human cytomegalovirus and natural killer-mediated surveillance of HLA class I expression: a paradigm of host-pathogen adaptation.

M López-Botet1, M Llano, M Ortega.   

Abstract

Among various strategies to evade the host immune response, some viruses like human cytomegalovirus (HCMV) interfere with surface MHC class I expression and antigen presentation to T lymphocytes. The ability of natural killer (NK) cells to detect MHC class I molecules through inhibitory receptors can be envisaged as an adaptation of the immune system for responding to such pathological alterations. To fulfil that role, rodents use members of the Ly49 C-type lectin superfamily, whereas primates employ killer immunoglobulin-like receptors and the immunoglobulin-like transcript 2/leucocyte immunoglobulin-like receptor-1 receptor. CD94/NKG2 lectin-like heterodimers represent the most conserved receptor system for MHC class I molecules; by interacting with human HLA-E or murine Qa-1b, CD94/NKG2A inhibitory receptors broadly probe the biosynthesis pathway of other class I molecules. Reciprocally, HCMV has developed mechanisms to evade the NK response while modulating HLA class Ia expression. The ability of HCMV to maintain surface levels of HLA-E and to express an HLA class I surrogate (UL18) are herein discussed in the context of the interplay with human NKR systems.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11513140     DOI: 10.1034/j.1600-065x.2001.1810116.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  9 in total

1.  NKG2A and CD56 are coexpressed on activated TH2 but not TH1 lymphocytes.

Authors:  Robert J Freishtat; Lindsay W Mitchell; Svetlana D Ghimbovschi; Samuel B Meyers; Eric P Hoffman
Journal:  Hum Immunol       Date:  2006-03-27       Impact factor: 2.850

Review 2.  Immune evasion of natural killer cells by viruses.

Authors:  Stipan Jonjić; Marina Babić; Bojan Polić; Astrid Krmpotić
Journal:  Curr Opin Immunol       Date:  2008-02       Impact factor: 7.486

3.  Equine herpesvirus type 4 UL56 and UL49.5 proteins downregulate cell surface major histocompatibility complex class I expression independently of each other.

Authors:  Abdelrahman Said; Walid Azab; Armando Damiani; Nikolaus Osterrieder
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

4.  Crystal structure of the murine cytomegalovirus MHC-I homolog m144.

Authors:  Kannan Natarajan; Ashleigh Hicks; Janet Mans; Howard Robinson; Rongjin Guan; Roy A Mariuzza; David H Margulies
Journal:  J Mol Biol       Date:  2006-02-09       Impact factor: 5.469

Review 5.  Structural and functional diversity of the lectin repertoire in teleost fish: relevance to innate and adaptive immunity.

Authors:  Gerardo R Vasta; Mihai Nita-Lazar; Barbara Giomarelli; Hafiz Ahmed; Shaojun Du; Matteo Cammarata; Nicolò Parrinello; Mario A Bianchet; L Mario Amzel
Journal:  Dev Comp Immunol       Date:  2011-08-30       Impact factor: 3.636

6.  Enhanced oncolytic potency of vesicular stomatitis virus through vector-mediated inhibition of NK and NKT cells.

Authors:  J Altomonte; L Wu; M Meseck; L Chen; O Ebert; A Garcia-Sastre; J Fallon; J Mandeli; S L C Woo
Journal:  Cancer Gene Ther       Date:  2008-10-10       Impact factor: 5.987

Review 7.  Murine cytomegalovirus regulation of NKG2D ligands.

Authors:  Tihana Lenac; Jurica Arapović; Luka Traven; Astrid Krmpotić; Stipan Jonjić
Journal:  Med Microbiol Immunol       Date:  2008-02-08       Impact factor: 3.402

8.  Killing of Kaposi's sarcoma-associated herpesvirus-infected fibroblasts during latent infection by activated natural killer cells.

Authors:  Nick C Matthews; Martin R Goodier; Rebecca C Robey; Mark Bower; Frances M Gotch
Journal:  Eur J Immunol       Date:  2011-05-27       Impact factor: 5.532

9.  Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity.

Authors:  Claire Dunn; N Jan Chalupny; Claire L Sutherland; Stephanie Dosch; P V Sivakumar; David C Johnson; David Cosman
Journal:  J Exp Med       Date:  2003-06-02       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.